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Background: Inflammation and pain underlies several pathological conditions. Synthetic drugs used for the
management of these conditions carry severe toxic effects. Globally efforts are ongoing to introduce novel
medicinal plants to develop effective, economic and innocuous drugs. The current study was aimed at investigating
the antipyretic, anti-inflammatory and analgesic activity of methanol extract of A. hydaspica aerial parts (AHM) and
its active fraction. Furthermore identification and isolation of polyphenolic compounds was carried out to identify
the active principles.
Methods: Yeast induced pyrexia, Paw edema, acetic acid-induced writhing and hot plate test were carried out
in vivo. HPLC-DAD analysis and combination of different chromatographic techniques, involving vacuum liquid
chromatography (VLC) and flash chromatography (FC) were carried out for chemical characterization. The structural
heterogeneity of flavanols was characterized by ESI- MS, 1H NMR, 13C NMR and 2D NMR spectroscopic analyses, and
also by comparison with reported literature.
Results: Oral administration of A. hydaspica methanol extract (AHM) and A. hydaspica ethyl acetate fraction (AHE),
showed dose and time dependent decrease in body temperature in yeast induced pyrexia, comparable to standard,
Paracetamol. AHM and AHE (150 mg/kg) significantly (p < 0.001) inhibit pain sensation in various pain models, i.e.
acetic acid induced writhing and hot plate test. Similarly AHM and AHE demonstrated an anti-inflammatory effect
in carrageenan-induced paw edema in rats and 150 mg/kg dose being distinctly more effective (91.92% inhibition).
When studied on prostaglandin E2 (PGE2) induced edema in rats, AHM and AHE showed maximum inhibition of
edema at 150 mg/kg after 4 h. HPLC chromatogram of AHM revealed the presence of gallic acid, catechin, rutin
and caffeic acid. Chromatographic separation and structure characterization of AHE, has led to the identification of
three flavan-3-ol derivative including 7-O-galloyl catechin, +catechin and methyl gallate, which have been reported
for the first time in A. hydaspica.
Conclusion: These results revealed that the presence of bioactive compounds in A. hydaspica might be responsible
for the pharmacological activities, confirming the indigenous utility of A. hydaspica against inflammatory disorders.
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For centuries people of developing countries like Pakistan,
India and China, rely on traditional medicinal system for
the cure of various ailments as substitute health care
services due to safety and cost-effectiveness of herbal
medications. In different regions of Pakistan local practice
of medicinal plants for curing number of diseases is very
common. In Pakistan medicinal plants prescribers called
Tabib/Hakim use approximately 600–1000 medicinal
plants of the country based on their experience, without
scientific knowledge for the treatment of wide range of
disorders [1]. Certainly local practice of plants is unre-
stricted in developing countries, but it is obligatory to as-
certain the pharmaceutically vital agents responsible for
protection against fatal diseases. Currently developed
world is also inclined towards complementary and alterna-
tive medicines, specifically derived from natural source. At
the present, varieties of herbal plants have been exten-
sively used as a curative agent for various infectious
diseases globally. It is anticipated that about one quarter
of approved modern medicines has been derived from
botanicals [2].
Inflammation, pain and pyrexia underlie several patho-
logical conditions. Synthetic drugs, i.e. NSAIDs, opioids
and corticosteroids are clinically most important drugs
used for the treatment of inflammatory disorders, how-
ever their long term use may induce toxic effects inclu-
ding; gastrointestinal ulcers, bleeding, renal disorders
etc. [3,4]. Globaly efforts are ongoing to introduce novel
medicinal plants to develop effective, economic and
innocuous drugs [5]. Medicinal plants are believed to be
an important source of useful compounds with potential
therapeutic effects. The research on plants with apparent
folkloric use, as agony relievers, anti-inflammatory agents,
should therefore be regarded as a prolific and a rational
research strategy in the search for new anti-inflammatory
drugs [6].
A. hydaspica R. Parker belongs to family Leguminosae.
This species is reported to be common in Iran, India
and Pakistan, commonly used as fodder, fuel and wood
[7]. It is treated as a synonym of A. eburnea [8]. The
bark and seeds are the source of tannins. The plant is lo-
cally used as antiseptic. The traditional healers of India
use various parts of the plant for the treatment of diar-
rhea; the leaves and the bark are useful in arresting se-
cretion or bleeding. The pods are helpful in removing
catarrhal matter and phlegm from the bronchial tubes.
The gum dispels irascibility of the skin and soothes the
inflamed membranes of the pharynx, alimentary canal
and genito-urinary organs (http://trade.indiamart.com/
details.mp?offer=6763150691). Different species of Acacia
were evaluated for their anti-inflammatory, antipyretic
and analgesic activities in various animal models. Aqueous
extract of the bark of A. karroo provided remarkable anti-inflammatory activity against the carrageenan and hista-
mine induced edema and analgesic activity via acetic acid
induced writhing model in experimental animals [9].
Bukhari et al. evaluated the analgesic, anti-inflammatory
and antiplatelet activities of the methanol extract of
A. modesta by using acetic acid, formalin, hot plate
and carrageenan induced edema in rodents [10]. Acute
(xylene- induced) and chronic (cotton pellet-induced)
anti-inflammatory effects of A. nilotica have been inves-
tigated in rat [11]. Petroleum ether, chloroform and
methanol extract of A. comigera were evaluated against
croton oil induced dermatitis in mice [12]. Ethanol ex-
tract of the seeds of A. suma was evaluated against the
carrageenan induced hind paw edema in rat model,
whereas analgesic activity was evaluated by acetic acid
induced writhing and formalin induced linking tests in
mice [13]. A. nilotica extract showed inhibitory effect
on carrageenan induced paw edema and yeast induced
pyrexia in rats [14].
Till date, no pharmacological study has been con-
ducted to evaluate the antipyretic, anti-inflammatory,
and analgesic activity of A. hydaspica, supporting tradi-
tional uses of this plant in folklore medicine. Hence the
present study was undertaken to evaluate the antipyretic,
anti-inflammatory and analgesic activity of methanol ex-
tract and its derived fractions using rat model. Further-
more HPLC finger printing and compounds isolation was
performed to identify the active principle compounds re-
sponsible for various pharmacological activities.
Methods
Plant collection
The aerial parts (bark, twigs, and leaves) of A. hydaspica
were collected from Kirpa area Islamabad, Pakistan in
the month of April 2011. After identification with the
help of relevant literature, voucher specimen (0642531)
was assigned and the herbarium specimen was submit-
ted in the Herbarium of Pakistan, Museum of Natural
History, Islamabad for future reference.
Extraction
Shade dried aerial parts (bark, twigs, and leaves) of A.
hydaspica were ground in to powder (3 kg) and soaked
for 14 days in crude methanol, with occasional shaking.
The extract was filtered through filter paper (Whatman
filter paper number 45), and concentrated under vacuum
using a rotary evaporator (Buchi, R114, Switzerland) at
40°C and 472 g of A. hydaspica crude methanol extract
(AHM, 15.73%) was obtained. Partial purification or sepa-
ration of AHM was done by solvent-solvent extraction.
Briefly 12 g of AHM was suspended in 500 ml distilled
water in separating funnel (1000 ml) and successively
partitioned with n-Hexane, Ethyl-acetate, Chloroform and
n-Butanol. Each extraction process was repeated three
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peated to get enough mass of fractions for various bioacti-
vity testing and chromatographic separation. These solvents
with varying polarities theoretically partitioned different
plant constituents. The filtrate was concentrated using ro-
tary evaporator and weighed to determine the resultant
mass. After this initial partitioning we got four soluble frac-
tions; A. hydaspica n-hexane fraction (AHH, 5.27% yield),
A. hydaspica ethyl acetate fraction (AHE, 27.77% yield),
A. hydaspica chloroform fraction (AHC, 1.94% yield), A.
hydaspica n-butanol fraction (AHB, 41.66% yield) and
remaining aqueous fraction (AHA, 8.05% yield). The AHE
showed to be the most active fraction and AHH, AHC,
AHB and AHA fractions were not found active in any of
the assays carried out in this study. AHM was subjected
to High Performance Liquid Chromatography (HPLC) for
compound fingerprinting and AHE was subjected to chro-
matographic isolation for further fractionation and purifi-
cation of polyphenolics.
Compositional analysis by HPLC
HPLC analysis of AHM was carried out by using HPLC-
DAD (Agilent Germany) equipment using Sorbex RX-
C8 (Agilent USA) analytical column with 5 μm particle
size. Mobile phase consisted of eluent A, (acetonitrile–
methanol–water–acetic acid /5: 10: 85: 1) and eluent B
(acetonitrile-methanol-acetic acid/40: 60: 1). The gra-
dient (A: B) utilized was the following: 0–20 min (0 to
50% B), 20–25 min (50 to 100% B), and then isocratic
100% B (25-40 min) at flow rate of 1 ml/min, and injec-
tion volume was 20 μl. Rutin and Gallic acid were ana-
lyzed at 257 nm, catechin and apigenin at 279 nm,
caffeic acid at 325 nm and quercitin, myricetin, kaem-
pherol were analyzed at 368 nm. Every time column was
reconditioned for 10 min before the next analysis. All
samples were assayed in triplicate. Quantification was
carried out by the integration of the peak using the ex-
ternal standard method. All chromatographic operations
were carried out at ambient temperature.
Isolation of compounds
The scheme of fractionation and isolation is explained in
flow chart (Figure 1). Briefly 10 g of A. hydaspica ethyl
acetate fraction (AHE) was dissolved in DCM (Dichloro-
methane), mixed with neutral acid wash (super cell NF)
and dried down completely with rotavap. Dried extract
sample was loaded on silica gel using glass column
packed with silica (200–400 mesh), attached with vac-
uum line source (vacuum liquid chromatography, VLC).
The column was eluted with dichloromethane (DCM),
then DCM-methanol mixture in increasing order of po-
larity and 10 fractions were collected (1 L each), and
three major phenolic fractions (VLC-AHE/F4-F6) se-
lected on the basis of TLC (silica gel 60 F254 plates,MERCK) and 1HNMR spectra similarity, and were com-
bined, and subjected to flash liquid chromatography,
carried on Combi-flash Teledyne ISCO using silica and
column eluted with mixture of DCM: Methanol in
increasing order of polarity. Spectra were monitored at
all wavelengths (200 nm-780 nm) with Peak width
2 min, and Thresh hold 0.02 AU. 146 fractions collected
with ISCO were pooled into 27 fractions according to
their TLC and ISCO chromatogram spectral peaks.
1HNMR of ISCO fractions indicated the presence of
chromatographically pure compounds IF 9 (C1), IF7
(C2) and IF3 (C3); Structures of isolated compounds
were determined by NMR assignments.
Nuclear magnetic resonance spectroscopy (NMR)
1H- and 13C-NMR spectrum for all compounds was re-
corded on a CDD NMR instrument: Varian 600 MHz
(1H and 13C frequencies of 599.664 and 150.785 MHz,
respectively) at 25°C. Spectra of all compounds were ob-
tained in Methanol-d4 and DMSO-d6. Conventional 1D
and 2D Fourier transform techniques were employed as
necessary to achieve unequivocal signal assignments
and structure proof for all compounds independently.
Stereo-chemical assignments were made with ROESY
and NOESY experiments. Detailed analysis of resolution
enhanced spectra (Peak picking, integration and multiplet
analysis) was performed using Varian NMR and ACD/
NMR processor, Academic Edition. The NMR spectra and
chemical shifts of isolated compounds were compared
with published data.
Animals
Sprague Dawley rats (180-220 g) of either sex, maintained
at primate facility Quaid-i-Azam University Islamabad,
Pakistan were used for the study. Animals were kept
at standard conditions of temperature (25 ± 1°C) and
12/12 h light/dark cycle, have free access to standard la-
boratory feed and water. All experimental procedures
involving animals were conducted in accordance with the
guidelines of the National Institutes of Health (NIH
guidelines). The study protocols were approved by Ethical
committee of Quaid-i-Azam University Islamabad. Six
animals were used in each group. Experiments on animals
were performed in accordance with the guidelines of the
institute of animal ethical committee, NIH, Islamabad.
Acute toxicity study
The acute toxicity studies were conducted as per the
guidelines 425 of Organization for Economic Cooperation
and Development (OECD) for testing of chemicals for
acute oral toxicity [15]. Rats (n = 6) of either sex treated
with different doses (50, 250, 500, 1000, 2000 and
3000 mg/kg, p.o.), while the control group received saline
(10 ml/kg). All the groups were observed up to 6 h for any
Figure 1 Schematic representation of extraction and isolation of compounds from A. hydaspica.
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24 h of treatment.
Pharmacological activities
Antipyretic activity
The antipyretic activity of AHM and its active fraction
AHE was evaluated using Sprague Dawley rats (180–220 g)of either sex using previously explained method [16]. The
selected animals were healthy and normal body tem-
perature of each rat was checked by using digital ther-
mometer. Pyrexia was induced in all rats by injection of
20% aqueous suspension of brewer’s yeast (Saccharomyces
cerevisiae) 10 ml/kg. Subcutaneous (SC). All animal
groups (6/group) were fasted with access to only water,
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temperature of each rat was recorded and pyrexia was con-
firmed by increase in temperature more than 1°C, while
animals showing less than 1°C rise in temperature were ex-
cluded from the experiment. The group I received saline
(10 ml/kg), group II received paracetamol (100 mg/kg) as a
standard drug, while group III-XII received 50, 100 and
150 mg/kg, p.o. doses (through feeding tubes) of AHM
and AHE respectively. The rectal temperature of the
groups was recorded at 1 h intervals for 5 h.
Anti-inflammatory activity
Carrageenan induced paw edema The anti-inflammatory
activity was performed on rat of either sex (180-220 g).
The normal paw volumes of all the rats were measured ab
initio and animals were divided into different groups, each
consisting of six rats [1]. The group I was treated with nor-
mal saline (10 ml/kg, i.p.), Group II, III and IV with the
standard drugs i.e. diclofenac sodium, aspirin and fluoxet-
ine (10 mg/kg) respectively while rest of the groups were
treated with AHM and AHE (50, 100 and 150 mg/kg,
p.o.). After thirty minutes of the above intra-peritoneal
and oral administration, carrageenan (1%, 0.1 ml) was
given subcutaneously into the sub plantar tissue of the
right hind paw of each rat. The paw volume was quantified
using digital plethysmometer before and at 1st, 2nd, 3rd and
4th h after carrageenan administration. The edema volume
of paw and percent inhibition of edema were calculated
using the following formulae:
EV ¼ PVA−PVI
EV = edema volume, PVI = Paw volume before carrageenan
administration (i.e. initial paw volume) and, PVA= Paw
volume after carrageenan administration.




EVc = Edema volume of control animals, EVt = Edema
volume of test drug animals.
Prostaglandin E2-induced paw edema Rats of either
sex were divided into different groups (n = 6) and treated
intraperitoneal with saline (control), Diclofenac Sodium
(10 mg/kg, i.p., reference standard), AHM and AHE (50,
100 and 150 mg/kg orally). After 30 min of treatment,
100 μl of prostaglandin E2 (0.01 μl/ml) was administered
into the sub planter side of right hind paw of each rat,
and the edema size was determined as aforesaid [17].
Analgesic activity
Acetic acid induced writhing test The method used in
this test has previously been described by khan et al.
[18]. Total number of writhing movements following i.p.administration of acetic acid solution (10 ml/kg, 1%) was
recorded over a period of 10 min, starting 5 min after
acetic acid injection. Rats were treated with AHM and
AHE (50, 100 and 150 mg/kg), vehicle (saline), standard
drugs (diclofenac sodium and aspirin 10 mg/kg), 30 min
before acetic acid injection [19]. The numbers of writh-
ings movements (Constriction of abdominal muscles
along with the stretching of hind limbs) were counted in
both untreated and treatment groups and percentage in-
hibition in abdominal writhings was calculated as follow.





W=No. of writhing, c = Control, and t = Test.
Hot plate test The procedure described by Muhammad
et al. [1], was followed to perform this test. Sprague
Dawley rats of either sex (n = 6) weighing 180–220 g were
used. Animals were subjected to pre-testing on a hot plate
(Harvard apparatus) maintained at 55 ± 0.1°C. Animals
having latency time greater than 15 sec on hot plate
during pre-testing were excluded. Animals were divided
randomly into 5 groups, each containing of six rats. The
group I was treated with saline (10 ml/kg), group II and
III with diclofenac sodium and fluoxetine (10 mg/kg, i.p.),
and Group IV-IX were treated with oral doses of 50, 100
and 150 mg/kg of AHM and AHE respectively. Diclofenac
sodium and fluoxetine were used as reference drugs for
comparison [19,20]. After 30 min of dose administration,
rats were dropped inside the cylinder onto the hot plate
and the latency time (time for which rat remains on the
hot plate without licking or flicking of hind limb or jump-
ing) was recorded in seconds. In order to prevent the
tissue damage the cut off time of 30 sec was set for all ani-
mals. The latency time was recorded for each group at 0,
30, 60, 90 and 120 min following drug administration. Per-
cent analgesia was calculated using the following formula.
% Analgesia ¼ Test latency – control latencyð Þ
Cut off time−control latencyð Þ  100
 
Statistical analysis
All values were expressed as mean ± SEM and data were
analyzed by Graph pad using One-way analysis of va-
riance followed by Tukey’s multiple comparison test and
Two-way analysis of variance (ANOVA) followed by
Bonferroni multiple comparison test. p < 0.05 was con-
sidered significant.
Results
Estimation of acute toxicity
AHM and AHE found safe at all tested doses (up to
3000 mg/kg) and did not show any noxious symptom in
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During the 48 h assessment, no mortality was found.
Antipyretic activity
The AHM and AHE significantly (p < 0.001) attenuated
hyperthermia in rats. The mean increase in rectal
temperature recorded after 24 h of yeast injection, was
2°C-2.43°C. The inhibition was dose dependent and re-
mained significant up to 5 h of administration. AHE
150 mg/kg dose showed the maximum antipyretic effect
and return body temperature to normal levels (p > 0.05)
more efficiently than standard drug paracetamol (Table 1).
Anti-inflammatory activity
Carrageenan induced paw edema
In the carrageenan-induced edema, crude extract of A.
hydaspica (AHM) and its fraction (AHE), induced a dose
and time dependent reduction in paw edema. The anti-
inflammatory activity became significant (p < 0.05), 2 h
after carrageenan injection by 150 mg/kg dose whilst;
maximum inhibition was observed after 4 h. The percent
inhibition of inflammation by AHM (150 mg/kg) was more
pronounced than aspirin, whilst the inflammatory activity
revealed by diclofenac sodium was non-significantly diffe-
rent from AHM (Table 2).
Prostaglandin induced paw edema
AHM and AHE revealed a dose dependent (50-15 mg/kg)
and time dependent reduction in prostaglandin E2 (PGE2)
induced paw edema in rats. Reversal of edema starts 2 h
after the injection of PGE2, and peak inhibition was seen
after 4 h. The AHE induced anti-inflammatory activity
comparable to standard reference drug (Table 3).
Peripheral analgesic effect
Acetic acid induced writhing test
Results showed that AHM and its derived fraction AHE
significantly (p < 0.001) and dose dependently (50, 100Table 1 Effect of AHM and its fraction on brewer’s yeast-indu
Treatment Dose mg/kg Body
temp. (N)
Rectal temperature (°C)
After administration of drug
After 24 h (T) 1 h (P1)
Saline 10 ml 36.96 ± 0.21 38.96 ± 0.02 38.88 ± 0.09
Paracetamol 100 37.36 ± 0.25 39.35 ± 0.21 38.70 ± 0.27
AHM 50 37.23 ± 0.12 39.03 ± 0.06 39.32 ± 0.12
100 36.85 ± 0.05 39.17 ± 0.08 39.05 ± 0.08
150 37.30 ± 0.1 39.53 ± 0.18 39.20 ± 0.14
AHE 50 37.19 ± 0.10 39.43 ± 0.54 38.82 ± 0.41
100 36.85 ± 0.05 38.67 ± 0.44 38.6 ± 0.489
150 37.10 ± 0.10 39.18 ± 0.28 38.55 ± 0.45
Data values shown represent mean ± SEM (n = 6). *p < 0.05, **p < 0.01, ***p < 0.001
Bonferroni multiple comparison test). N indicates mean body temperature before pand 150 mg/kg), reduced the number of abdominal
constriction induced by administration of 1% acetic acid
solution. The inhibitory effect of Diclofenac sodium was
non-significantly different from the protective effect
revealed by AHM and AHE (100-150 mg/kg dose)
(Table 4).
Central analgesic effect
Hot plate method (Thermal stimulation)
In this assay A. hydaspica methanol extract (AHM) and
its ethyl acetate fraction (AHE) exhibited a dose de-
pendent increase in latency time and inhibited pain
sensation in a pattern similar to standard drug; diclo-
fenac sodium whilst the effect of both AHM and AHE,
was shown to be more pronounced than fluoxetine at
150 mg/kg dose (Figure 2, Table 5).
HPLC analysis
To establish the fingerprint chromatogram for AHM,
Gallic acid, catechins, caffeic acid, rutin, apigenin, kaemp-
ferol, myricetin and quercetin were used as markers.
HPLC chromatogram revealed the presence of gallic acid,
catechin, caffeic acid, and rutin by comparison with reten-
tion time and UV absorbance of purified standards. The
relative amounts of the four phenolic compounds found
in AHM were in the order of catechin (558.9 μg/100 mg
dry sample) >Gallic acid (300.051 μg/100 mg dry sam-
ple) > rutin (235.38 μg /100 mg dry sample) > caffeic acid
(137.43 μg/100 mg dry sample), respectively (Figure 3).
Phytochemistry of AHE
The ethyl-acetate fraction of A. hydaspica methanol
extract was fractionated by VLC chromatography and
ISCO flash chromatography to afford several enriched
fractions and three pure compounds C1, C2 and C3. Iso-
lated compounds were identified as 7-O-galloyl catechin
(C1), catechin (C2) [20,21] and methyl gallate (C3) [22]
by comparison of their 1D and 2D NMR spectral dataced pyrexia
2 h (P2) 3 h (P3) 4 h (P4) 5 h (P5)
38.73 ± 0.03 38.62 ± 0.02 38.55 ± 0.06 38.5 ± 0.014
37.99 ± 0.07* 37.79 ± 0.04* 37.49 ± 0.02** 37.395 ± 0.02***
38.47 ± 0.084 38.15 ± 0.05 37.91 ± 0.03 37.77 ± 0.14
38.12 ± 0.021 37.94 ± 0.06 37.76 ± 0.05* 37.12 ± 0.03***
38.05 ± 0.09*** 37.86 ± 0.04*** 37.62 ± 0.03* 37.36 ± 0.06***
38.01 ± 0.014 37.99 ± 0.01 37.68 ± 0.045* 37.24 ± 0.239***
37.88 ± 0.03* 37.475 ± 0.324** 37.31 ± 0.19*** 36.75 ± 0.245***
37.62 ± 0.02** 37.625 ± 0.494** 37.195 ± 0.005*** 37.13 ± 0.12***
versus only brewer’s yeast treated group (Two-way ANOVA followed by
yrexia.
Table 2 Effect of AHM and its fraction on carrageenan-induced paw edema in rats




Increase in paw volume (ml) after carrageenan injection (mean ± SEM)/Percent
inhibition of edema
+1 h +2 h +3 h +4 h
Saline 2 ml, i.p. 1.2 ± 0.0265 2.66 ± 0.015 2.5 ± 0.095 2.24 ± 0.104 1.93 ± 0.053
AHM 50 mg/kg, p.o. 1.043 ± 0.03 2.488 ± 0.045 1.82 ± 0.062 1.56 ± 0.047 1.39 ± 0.032
(1.34 ± 0.917) (40.23 ± 0.413) (52.29 ± 3.12) (52.46 ± 2.419)
100 mg/kg, p.o. 0.89 ± 0.04 2.311 ± 0.03 1.543 ± 0.02 1.301 ± 0.015 1.156 ± 0.05
(3.11 ± 1.6) (49.41 ± 2.023) (60.47 ± 0.429*) (63.47 ± 0.457*)
150 mg/kg, p.o. 1.01 ± 0.037 2.423 ± 0.043 1.49 ± 0.07 1.27 ± 0.060 1.119 ± 0.06
(3.63 ± 1.135) (63.07 ± 0.09*) (75 ± 0.23**) (85.06 ± 1.47**)
AHE 50 mg/kg, p.o. 1.05 ± 0.05 2.473 ± 0.013 1.797 ± 0.039 1.473 ± 0.046 1.343 ± 0.029
(2.295 ± 0.10) (46.64 ± 0.63***) (69.56 ± 0.564***) (78.29 ± 1.000***)
100 mg/kg, p.o. 1.01 ± 0.29 2.307 ± 0.036 1.491 ± 0.010 1.274 ± 0.37 1.09 ± 0.51
(2.50 ± 0.20) (67.14 ± 0.500***) (81.159 ± 0.5***) (92.07 ± 1.00***)
150 mg/kg, p.o. 1.01 ± 0.5 2.403 ± 0.05 1.46 ± 0.026 1.178 ± 0.019 1.036 ± 0.036
(3.86 ± 0.428) (67.85 ± 1.00***) (87.82 ± 1.00***) (93.40 ± 1.00***)
Diclofenac sodium 10 mg/kg, i.p. 1.19 ± 0.015 2.576 ± 0.03 1.600 ± 0.02 1.426 ± 0.0305 1.27 ± 0.01
(5.52 ± 0.575) (68.46 ± 0.815**) (77.24 ± 0.192**) (89.04 ± 2.048***)
Fluoxetine 10 mg/kg, i.p. 1.09 ± 0.064 2.50 ± 0.091 1.63 ± 0.04 1.343 ± 0.055 1.192 ± 0.017
(3.86 ± 0.212) (58.461 ± 1.972*) (75.64 ± 0.093**) (85.98 ± 2.008**)
Aspirin 10 mg/kg, i.p. 1.157 ± 0.04 2.597 ± 0.032 1.736 ± 0.075 1.486 ± 0.066 1.34 ± 0.0264
(1.84 ± 0.50) (55.46 ± 0.246*) (68.30 ± 0.094**) (74.93 ± 5.15**)
Data values shown represent mean ± SEM (n = 6). *p < 0.05, **p < 0.01, ***p < 0.001 versus only carrageenan treated group (Two-way ANOVA followed by
Bonferroni multiple comparison test). Percentage inhibition is shown in brackets. Inhibition in saline treated group at each time point was calculated relative to
paw edema after 1 h.
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shown the structure of isolated flavanols from AHE. A.
hydaspica ethyl-acetate extract (AHE) yields 187.5 mg/g
of Compound 1, 100 mg/g of Compound 2 and 37.5 mg/g
of Compound 3 (Figure 4).
Discussion
To the best of our knowledge this is the first report on
antipyretic, analgesic and anti- inflammatory activities of
A. hydaspica methanol extract of arial parts and its de-
rived ethyl acetate fraction (AHE). Present investigationTable 3 Effect of AHM and its fraction on prostaglandin E2-in
Treatment Dose/route Percent inhibition
+1 h
AHM 50 mg/kg, p.o. 2.44 ± 0.29
100 mg/kg, p.o. 3.76 ± 0.176
150 mg/kg, p.o. 4.16 ± 0.176
AHE 50 mg/kg, p.o. 4.72 ± 0.355
100 mg/kg, p.o. 4.33 ± 0.12
150 mg/kg, p.o. 4.80 ± 0.152
Diclofenac sodium 10 mg/kg, i.p. 5.13 ± 0.145
Data values shown represent mean ± SEM (n = 6). ***p < 0.001 versus only PGE2 treashowed that the AHM and AHE possess noticeable anti-
pyretic, analgesic and anti-inflammatory properties with
a reasonable protection profile.
HPLC analysis of AHM extract shows the presence of
bioflavonoids, Gallic acid, catechin, caffeic acid and
rutin, which were identified for the first time in subject
plant. Furthermore chemical investigation of AHE re-
sulted in isolation of 7-O-galloyl catechin, +catechin and
methyl gallate.
Gallic acid revealed anti-inflammatory activity by in-
terfering with the functioning of polymorphonuclearduced paw edema in rats
of edema Volume
+2 h +3 h +4 h
18.58 ± 1.744*** 52.25 ± 1.52*** 54.186 ± 3.13***
33.31 ± 1.084*** 72.86 ± 2.081*** 75.19 ± 2.62***
42.50 ± 1.76*** 86.72 ± 3.45*** 86.11 ± 1.41***
24.16 ± 1.20*** 64.34 ± 1.88*** 75.68 ± 2.61***
37.77 ± 1.36*** 77.21 ± 2.23*** 84.12 ± 0.90***
59.338 ± 3.05*** 90.57 ± 0.76*** 91.345 ± 0.57***
55.83 ± 2.63*** 87.72 ± 2.53*** 88.11 ± 0.68***
ted group (Two-way ANOVA followed by Bonferroni multiple comparison test).







Saline 10 ml/kg 70.38 ± 2.7 0
AHM 50 mg/kg,p.o. 27.65 ± 1.005*** 60.71 ± 0.66
100 mg/kg, p.o. 18.09 ± 1.24*** 74.29 ± 1.20
150 mg/kg, p.o. 16.15 ± 1.175*** 77.05 ± 1.70
AHE 50 mg/kg,p.o. 18.25 ± 1.25*** 74.06 ± 1.15
100 mg/kg, p.o. 15.00 ± 1.00*** 78.68 ± 1.05
150 mg/kg, p.o. 12.75 ± 1.25*** 81.88 ± 0.05
Diclofenac sodium 10 mg/kg, i.p. 13.22 ± 1.89*** 81.65 ± 1.10
Aspirin 10 mg/kg, i.p. 20.13 ± 1.12*** 71.39 ± 2.00
Data values shown represent mean ± SEM (n = 6). ***p < 0.001 versus only
acetic acid treated group (One-way ANOVA followed by Tukey’s Multiple
Comparison Test).
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oxidase. Presence of Gallic acid in AHM might be
contributing to strong anti-inflammatory activity as,
O-dihydroxy group of gallic acid is important for the in-
hibitory activity in vitro [23]. Caffeic acid exerted both
in vitro and in vivo anti-inflammatory effects probably
through modulation of iNOS expression and other in-
flammatory mediators. Catechin is the class of flavonoids
with potent cancer chemo-preventive, neuro-protective,
anti-apoptotic, and anti-inflammatory properties in
clinical disorders [24,25]. Rutin is an important plantFigure 2 Percent effect of AHM, AHE, diclofenac sodium and fluoxetine in hot
comparison test. Asterisks *** indicated statistically significant (p < 0.001) values
of AHM and AHE (150 mg/kg dose) to fluoxetine.secondary metabolite and reported as hepato-protective,
antioxidant, and anti-inflammatory agent [25].
AHE was also found to possess the most significant
pharmacological activities, which might be due to the
presence of isolated flavanols: 7-O-galloyl catechin, +catechin
and methyl gallate, previous data also affirmed that these
compounds possess anti inflammatory, analgesic and pain
relieving potential [26].
A subcutaneous injection of Brewer’s yeast induces
pyrexia (called as pathogenic fever) by increasing the
production of prostaglandins. Antipyretic activity is com-
monly mentioned as a characteristic of drugs or compounds
which have an inhibitory effect on prostaglandin-
biosynthesis and it is considered as a useful test for the
screening of plant materials as well as synthetic drugs
for their antipyretic potential [1]. AHM and its fraction
AHE exhibited significant antipyretic activity at 150 mg/kg
dose, comparable to paracetamol (standard drug). Inhi-
bition of prostaglandin synthesis by blocking the cyclooxy-
genase enzyme activity could be the possible mechanism
of antipyretic action as that of paracetamol. Besides that
antipyretic effect might be governed by the ability of
extract samples to reduce pro-inflammatory mediators,
improve anti-inflammatory signals at sites of injury, or
increase antipyretic messages within the brain [27]. The
observed effects might be due to the presence of pharma-
cologically active metabolites that might interfere with the
release of prostaglandins. However, it must be noted that
several biochemical events occur ultimately to the produc-
tion of prostaglandins. It may therefore be worthwhile toplate test. Data analyzed by Two-way ANOVA followed by Bonferroni
from the control, ### indicated statistically significant (p < 0.001) difference
Table 5 Effect of AHM and its fraction in hot plate test
Group Dose/route Latency time in seconds
0 min 30 min 60 min 120 min
Saline 10 ml, i.p. 9.83 ± 0.601 9.36 ± 0.317 9.3. ± 0.881 9.167 ± 0.44
AHM 50 mg/kg, p.o. 9.61 ± 0.1675 12.33 ± 0.881** 17.00 ± 0.577*** 18.33 ± 0.66***
100 mg/kg, p.o. 9.76 ± 0.145 17.0 ± 0.57*** 22.334 ± 1.201*** 24.0 ± 0.557***
150 mg/kg, p.o. 9.74 ± 0.52 20.66 ± 0.881*** 26.0 ± 0.577*** 26.33 ± 0.334***
AHE 50 mg/kg, p.o. 9.63 ± 0.185 13.0 ± 0.577*** 17.33 ± 0.667*** 19.33 ± 0.333***
100 mg/kg, p.o. 9.83 ± 0.167 17.66 ± 0.88*** 23.0 ± 0.577*** 24.33 ± 0.333***
150 mg/kg, p.o. 9.667 ± 0.166 22.0 ± 0.577*** 26.66 ± 0.33*** 27.0 ± 0.577***
Diclofenac sodium 10 mg/kg, i.p. 9.67 ± 0.667 21.66 ± 0.88*** 26.16 ± 0.89*** 26.66 ± 1.00***
Fluoxetine 10 mg/kg, i.p. 9.66 ± 0.881 15.33 ± 0.334*** 20.33 ± 0.90*** 21.33 ± 0.667***
Data values shown represent mean ± SEM (n = 6). **p < 0.01, ***p < 0.001 versus saline treated group (Two-way ANOVA followed by Bonferroni multiple
comparison test).
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where the extract exerts its antipyretic effect.
Carrageenan-induced paw edema is an acceptable pre-
liminary screening test for anti-inflammatory activity [28].
Carrageenan induces paw edema bi-phasically: the initial
phase extending from 0–2.5 h, predominantly results due
to the release of histamine, serotonin and bradykinin.
However, COX enzyme is known to play a key role in the
development of the later phase of inflammation by con-
verting arachidonic acid into prostaglandins. This enzyme
is considered to be identified target for a variety of
NSAIDs, such as aspirin and diclofenac sodium, which
inhibit rat paw edema at the later phase following carra-
geenan injection [29-31]. Therefore for comparison three
standards were used. AHM significantly (p < 0.001) inhi-
bited paw edema in the later phase in a pattern similar toFigure 3 HPLC chromatogram of AHM reveals the presence of Gallic acid,diclofenac sodium, whose mechanism of action is inhi-
bition of cyclooxygenase enzyme synthesis. Although the
actual mechanism of action is not known, it is possible
that, the anti-inflammatory activity exhibited by A. hydas-
pica extracts could be attributed to the inhibition of the
synthesis, release or action of inflammatory mediators.
Therefore; we tested AHM and AHE extracts against
PGE2 induced paw edema in rats. Results showed that
both extracts significantly reduced PGE2 induced edema
with maximum protection observed after 4 h. PGE2 is an
important mediator of second phase inflammation. These
results are in concordance with reported literature for
other Acacia species which possesses anti-asthmatic, anal-
gesic, anti-inflammatory, and antioxidant properties [32].
The inhibition of inflammation by extracts could be attri-
buted to the presence of active constituents.rutin, catechin and Caffeic acid.
Figure 4 Chemical structures of isolated polyphenols from A. hydaspica ethyl acetate fraction (AHE).
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method in evaluating the medicinal agents for the anal-
gesic potential. Pain sensation in acetic acid induced
writhing paradigm is elicited by producing a localized
inflammatory response due to the release of free arachi-
donic acid from tissue phospholipids via COX, and pro-
ducing prostaglandins specifically PGE2 and PGE2α, and
level of lipoxygenase products may also increase in peri-
toneal fluid [33-35]. These prostaglandins and lipoxyge-
nase product cause swelling and agony by the cumulativecapillary permeability and liberating endogenous sub-
stances that stimulate pain nerve endings. NSAIDs cause
inhibition of COX enzyme in the peripheral tissues and
affect the transduction mechanism of key afferent no-
ciceptors [36]. Our results of acetic acid-induced ab-
dominal constriction assay demonstrated a prominent
reduction in writhing reflux. The analgesic effect observed
at 150 mg/kg dose was comparable with the NSAID
standard drug diclofenac sodium (Table 4) [37,38]. These
findings strongly recommend that AHM and AHE
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and their mechanisms of action may be mediated through
inhibition of local peritoneal receptors via cyclooxygenase
inhibition.
Thermal nociception models such as hot plat tests were
used to evaluate the central analgesic activity. Both AHM
and AHE showed significant (p < 0.001) analgesic effect in
the hot plate test, implicating that plant extract may act as
a narcotic analgesic (Table 5). Diclofenac sodium induces
analgesic effect through activation of opioid receptors [39],
and the apparent similarity between the results of extracts
with standard diclofenac sodium, indicates that they might
work in a same manner to reduce pain sensation as diclofe-
nac sodium. The profound analgesic activity of A. hydas-
pica extracts might be due to the interference of their
active principle (s) with the release of pain mediators, as
the flavonoids increase the amount of endogenous sero-
tonin or may interact with 5-HT2A and 5- HT3 receptors
which may be involved in the mechanism of central anal-
gesic activity [38]. Diclofenac sodium, fluoxetine (10 mg/kg)
AHM, and AHE (150 mg/kg) raised the pain threshold
level within 30 min of administration. AHM and AHE
showed more pronounced analgesic effect at 150 mg/kg
dose than fluoxetine (10 mg/kg); stronger effects of plant
extracts than fluoxetine, is also in line with a proven con-
cept that medicinal plants possess a combination of con-
stituents, involving different mode (s) of action, offering
synergistic effects with no side effects. However the diffe-
rence in concentrations to achieve the maximum analgesic
point could be explained by differences in the metabolic
rate of each drug [40].
The presence of gallic acid, methyl gallate, 7-O-galloyl
catechin, catechin, rutin and caffeic acid in the other
species of the genus Acacia, their effect against COX
and 5-lopoxygenase and the antipyretic action of the
methanol extract of A. modesta leaves [10], supple-
mented the antipyretic, anti-inflammatory and analgesic
activities of our tested extracts and validated its ethno-
medicinal use as anti-inflammatory agent.
Conclusion
To conclude, the methanol extract of A. hydaspica aerial
parts (AHM) and its derived ethyl acetate fraction (AHE)
were evidenced as a natural safe remedy for the treatment
of pyrexia, pain and inflammation. Our current findings
demonstrated mechanistic evidence for why indigenous
people of Pakistan and India found it useful for inflamma-
tory disorders. Interestingly the findings that extracts ex-
hibited both peripheral as well as central analgesic effect
provide a rationale for developing opioids alternative which
leads to vomiting and nausea. The observed pharmaco-
logical activities might have been attributed to the presence
of active principles. But there is still need for entailment of
identification and acquaintance of molecular targets.Competing interests
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